Related Experiment Videos
[Alternative approaches in the end-stage heart failure]
Serkan Durdu1, Rüçhan Akar, Raif Cavolli
1Department of Cardiovascular Surgery, Ankara University School of Medicine, Ankara, Turkey.
Anadolu Kardiyoloji Dergisi : AKD = the Anatolian Journal of Cardiology
|September 12, 2003
Summary
Limited donor organs restrict cardiac transplantation, a leading treatment for end-stage heart disease. This report explores alternative surgical therapies for patients ineligible for or awaiting heart transplants.
Area of Science:
- Cardiology
- Transplantation Medicine
- Surgical Innovation
Context:
- Cardiac transplantation is the primary treatment for end-stage heart disease.
- Donor organ scarcity limits transplantation to only 1% of eligible candidates.
- Significant numbers of patients die while awaiting transplantation or face post-transplant complications.
Purpose:
- To review alternative surgical treatment options for end-stage heart disease.
- To address the limitations of donor organ availability in cardiac transplantation.
- To explore strategies for patients who do not meet transplant criteria.
Summary:
- Cardiac transplantation faces challenges including donor organ shortage, high waiting list mortality (20-40%), and post-transplant complications (20% first-year mortality, 5% annual thereafter).
- These limitations necessitate research into alternative therapeutic strategies beyond traditional transplantation.
- The report focuses on summarizing currently available alternative surgical methods for managing end-stage cardiac disease.
Impact:
- Provides a comprehensive overview of alternative surgical treatments for end-stage heart disease.
- Offers potential solutions for patients facing donor organ scarcity or transplant ineligibility.
- Highlights the ongoing need for innovation in cardiac failure management beyond transplantation.